Amy Elazzouzi
Net worth: 901 808 $ as of 29/09/2026
Net worth: 901 808 $ as of 29/09/2026
Amy Elazzouzi is currently Principal Financial Officer, Secretary & Treasurer at Aura Biosciences, Inc. since 2026.
Former positions include Director-Finance & Operations at Kew, Inc. and Controller at AVEO Pharmaceuticals, Inc. Education includes an MBA from Northeastern University and an undergraduate degree from Regis College.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
AURA BIOSCIENCES INC 0.14% | 31/08/2026 | 143,600 ( 0.14% ) | 901 808 $ | 29/09/2026 |
| Companies | Position | Start |
|---|---|---|
| AURA BIOSCIENCES, INC. | Director of Finance/CFO | 01/09/2026 |
| Companies | Position | End |
|---|---|---|
| AVEO PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | - |
Kew, Inc.
Kew, Inc. Medical/Nursing ServicesHealth Services Provides oncology services | Director of Finance/CFO | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Aura Biosciences, Inc.
Aura Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company leveraging novel targeted oncology platform to develop new standard of care across multiple cancer indications | Health Technology |
Northeastern University
Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Regis College
Regis College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AVEO Pharmaceuticals, Inc.
AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops cancer therapeutics | Health Technology |
Kew, Inc.
Kew, Inc. Medical/Nursing ServicesHealth Services Provides oncology services | Health Services |
Select your edition
All financial news and data tailored to specific country editions